Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of Hypoxia-inducible factor-1α

Molecular Pharmacology

Volumn 59, Issue 5, 2001, Pages 1216-1224

  Hur, Eunseon ^a   Chang, Keun Young ^a   Lee, Eunjung ^b   Lee, Seung Ki ^b   Park, Hyunsung ^a  

^a University of Seoul   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUTANT PROTEIN; PROTEASOME INHIBITOR; PROTEIN P44;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG INHIBITION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC STABILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REPORTER GENE; TRANSACTIVATION;

EID: 0035037527     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.5.1216     Document Type: Article

References (40)

1. An essential role for p300/CBP in the cellular response to hypoxia
2. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
3. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha
4. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
5. EPAS1 transactivation during hypoxia requires p42/p44 MAPK
6. Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum
7. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor and p300/CREB binding protein
8. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
9. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development
10. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2
11. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum
12. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase
13. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
14. 2-dependent degradation domain via the ubiquitin-proteasome pathway
15. 2 homeostasis by hypoxia-inducible factor 1 alpha
16. v-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
17. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
18. Activation of hypoxia-inducible factor1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor
19. Regulation of the hypoxia-inducible transcription factor1α by the ubiquitin-proteasome pathway
20. Activation of mitogen activated protein kinase in human platelets by Genistein
21. Vascular endothelial growth factor and its receptor
22. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site
23. Induction of phosphoglycerate kinase 1 gene expression by hypoxia: Roles of Arnt and HIF1α
24. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
25. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
26. ERK activation upon hypoxia: Involvement in HIF-1 activation
27. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
28. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1α
29. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit
30. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
31. p42/p44 Mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1*
32. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells
33. Hypoxia-inducible factorla (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions
34. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
35. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
36. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells mediated by increase in mRNA stability
37. Mitogen-activated protein kinase (Erk1/2) activation by sheer stress and adhesion in endothelial cells
38. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1
39. Purification and characterization of hypoxia-inducible factor 1
40. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases